Wang, Haiqing
Chen, Sen
Kang, Wenhui
Ding, Bojiao
Cui, Shulan
Zhou, Li
Zhang, Na
Luo, Huiying
Wang, Mingjuan
Zhang, Fan
Zhao, Zezhou
Guo, Zihu
Wang, Chao
Li, Liang
Wang, Zhengzhong
Chen, Xuetong
Wang, Yonghua
Article History
Received: 28 December 2022
Accepted: 20 February 2023
First Online: 23 February 2023
Declarations
:
: All animal protocols described in this study were approved by the Institutional Animal Care and Use Committee (IACUC: 2021091001, 2021112502) at the Kanion Parmaceutical. The IACUC protocol in this study follows the guidelines for the ethical review of laboratory animal welfare People’s Republic of China National Standard GB/T 35892-2018 (ExternalRef removed). The maximal tumor size/burden was not exceeded the permissible tolerance in IACUC protocol (< 2 cm).
: The authors have no relevant financial or non-financial interests to disclose.